主要文件

查看所有文档

50774-U

Ascentis^® Express 90 Å RP-Amide (5 μm) HPLC Columns

Name: Ascentis<SUP>&#174;</SUP> Express 90 Å RP-Amide (5 μm) HPLC Columns
Brand: SUPELCO

L × I.D. 15 cm × 4.6 mm, HPLC Column

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:

41115700

NACRES:

SB.52

L × i.d.:

15 cm × 4.6 mm

Particle size:

5 μm

Matrix active group:

amide, alkyl phase

Pore size:

90 Å pore size

Matrix:

Fused-Core^® particle platform, superficially porous particle

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

产品名称

Ascentis^® Express RP- 氨基化合物，5μm HPLC色谱柱, 5 μm particle size, L × I.D. 15 cm × 4.6 mm

material

stainless steel column

Quality Level

100

agency

suitable for USP L60

product line

Ascentis^®

feature

endcapped

manufacturer/tradename

Ascentis^®

packaging

1 ea of

parameter

60 °C temp. range, 600 bar max. pressure (9000 psi)

technique(s)

HPLC: suitable, LC/MS: suitable

L × I.D.

15 cm × 4.6 mm

surface area

90 m²/g

impurities

<5 ppm metals

matrix

Fused-Core^® particle platform, superficially porous particle

matrix active group

amide, alkyl phase

particle size

5 μm

pore size

90 Å pore size

pH range

2-9

application(s)

food and beverages

separation technique

reversed phase

说明

General description

Ascentis Express 5 μm RP-Amide是一款基于高效熔融核^®颗粒设计的高速、高效液相色谱柱。熔融核颗粒提供了围绕固体二氧化硅核的高纯度二氧化硅薄多孔外壳。由于在0.6 μm厚的多孔外壳中的浅扩散途径和5 μm的高度均匀的总粒度，该颗粒设计表现出非常高的柱效。Ascentis Express 5 μm RP-Amide的一步键合、封端、酰胺基、极性嵌入固定相提供了稳定的反相填料，具有降低的疏水性。Ascentis Express RP-Amide可用于具有C18或C8正交选择性的碱性、酸性或中性化合物。极性包埋的Ascentis Express 5 μm RP-Amide色谱柱与100%水性流动相相容，不会出现“相崩溃”。

Other Notes

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.

Still not finding the right product?

Explore all of our products under Ascentis^® Express RP- 氨基化合物，5μm HPLC色谱柱

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

A validated HPLC-MS/MS assay for quantifying unstable pharmacologically active metabolites of clopidogrel in human plasma: application to a clinical pharmacokinetic study.

Michael T Furlong et al.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 926, 36-41 (2013-04-02)

Clopidogrel is prescribed for the treatment of Acute Coronary Syndrome and recent myocardial infarction, recent stroke, or established peripheral arterial disease. A sensitive and reliable high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay was developed and validated to enable reliable

Simultaneous quantitative analyses of indole and oxindole alkaloids of Uncaria Hook in rat plasma and brain after oral administration of the traditional Japanese medicine Yokukansan using high-performance liquid chromatography with tandem mass spectrometry.

Hirotaka Kushida et al.

Biomedical chromatography : BMC, 27(12), 1647-1656 (2013-07-03)

Uncaria Hook (UH) alkaloids are involved in the beneficial effects of Yokukansan. However, the pharmacokinetics of UH alkaloids after oral administration of Yokukansan has not yet been sufficiently investigated. Therefore, we developed and validated a sensitive and specific high-performance liquid

Simultaneous and confirmative detection of multi-residues of β₂-agonists and β-blockers in urine using LC-MS/MS/MS coupled with β-receptor molecular imprinted polymer SPE clean-up.

S Fan et al.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 30(12), 2093-2101 (2013-10-22)

A liquid chromatography-linear ion-trap spectrometry (LC-MS³) method using β-receptor molecular-imprinted polymer (MIP) solid-phase extraction (SPE) as clean-up was developed to determine simultaneously and confirmatively residues of 25 β₂-agonists and 21 β-blockers in urine samples. Urine samples were subjected to enzymatic

查看所有相关文献

全球贸易项目编号

货号	GTIN
50774-U	04061838529077